ARCHIVES

IOM Review Of Duke Genomics Trials To Focus On Validation, Scientific Criteria

This article is from The Cancer Letter archive.

Vol. 36 No. 38 | October 22, 2010

Download PDF Visit The Full Archive

Related Articles

Gottlieb questions ODAC’s independence.

August 5, 2005

Letter: Palestinian Authority Not Yet A Country

June 14, 1996

ORI Finds Researcher Falsified Records

February 9, 1996

FDA, CMS Take Second Look at Drugs Given “Accelerated” Approval for Cancer

February 21, 2003

In Brief: Congress Asked To Investigate Dieldrin Danger; Harvard’s Rosenberg To Be NCI Surgery Chief

April 5, 1974

In Brief: Moffitt Center Makes Major Recruitment Effort; Komen Foundation Invites Award Nominations

May 28, 1993